NextCure Inc (NXTC)
1.70
+0.05
(+3.03%)
USD |
NASDAQ |
May 17, 16:00
1.70
0.00 (0.00%)
After-Hours: 20:00
NextCure Enterprise Value: -49.29M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | -49.29M |
| May 16, 2024 | -49.85M |
| May 15, 2024 | -49.57M |
| May 14, 2024 | -51.52M |
| May 13, 2024 | -51.24M |
| May 10, 2024 | -49.85M |
| May 09, 2024 | -47.89M |
| May 08, 2024 | -51.80M |
| May 07, 2024 | -51.80M |
| May 06, 2024 | -49.85M |
| May 03, 2024 | -53.20M |
| May 02, 2024 | -54.32M |
| May 01, 2024 | -57.68M |
| April 30, 2024 | -62.15M |
| April 29, 2024 | -63.27M |
| April 26, 2024 | -58.24M |
| April 25, 2024 | -59.92M |
| April 24, 2024 | -55.72M |
| April 23, 2024 | -53.31M |
| April 22, 2024 | -51.08M |
| April 19, 2024 | -51.36M |
| April 18, 2024 | -52.19M |
| April 17, 2024 | -53.87M |
| April 16, 2024 | -50.24M |
| April 15, 2024 | -49.40M |
| Date | Value |
|---|---|
| April 12, 2024 | -42.43M |
| April 11, 2024 | -43.54M |
| April 10, 2024 | -43.26M |
| April 09, 2024 | -43.26M |
| April 08, 2024 | -38.80M |
| April 05, 2024 | -35.17M |
| April 04, 2024 | -35.73M |
| April 03, 2024 | -29.03M |
| April 02, 2024 | -26.52M |
| April 01, 2024 | -31.54M |
| March 28, 2024 | -46.08M |
| March 27, 2024 | -54.31M |
| March 26, 2024 | -53.33M |
| March 25, 2024 | -52.77M |
| March 22, 2024 | -55.28M |
| March 21, 2024 | -61.42M |
| March 20, 2024 | -68.96M |
| March 19, 2024 | -68.40M |
| March 18, 2024 | -68.12M |
| March 15, 2024 | -67.84M |
| March 14, 2024 | -67.28M |
| March 13, 2024 | -65.05M |
| March 12, 2024 | -65.75M |
| March 11, 2024 | -64.77M |
| March 08, 2024 | -62.26M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-135.88M
Minimum
Dec 22 2022
1.918B
Maximum
Nov 05 2019
99.33M
Average
-53.00M
Median
Enterprise Value Benchmarks
| Assertio Holdings Inc | 59.35M |
| DiaMedica Therapeutics Inc | 73.83M |
| Terns Pharmaceuticals Inc | 140.94M |
| NovaBay Pharmaceuticals Inc | 5.156M |
| Palatin Technologies Inc | 22.26M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.11M |
| Total Expenses (Quarterly) | 15.76M |
| EPS Diluted (Quarterly) | -0.61 |
| Earnings Yield | -136.5% |
| Normalized Earnings Yield | -62.72 |